Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Sonder Capital is a venture capital firm founded in 2019 and based in the United States. The firm focuses on early-stage startups in the medical device, diagnostic, and healthtech sectors. Co-founders Jay Watkins and Fred Moll, M.D., bring extensive experience in creating and leading transformative healthcare companies. Sonder Capital is distinguished by its operator pedigree, with a team that has a proven track record in the medtech industry.
Currently, Sonder Capital is raising its second fund, with Kate Garrett serving as Managing Partner. The firm emphasizes active engagement with its portfolio companies, providing strategic advice and support from inception to acquisition or IPO. Sonder Capital is also committed to increasing diversity within the venture capital community, welcoming pitches from underrepresented individuals.
Sonder Capital invests in early-stage companies within the medical device, diagnostic, and healthtech sectors. The firm targets transformational innovations that can significantly impact patient outcomes and access to care. Their investment strategy focuses on opportunities that could lead to a market capitalization exceeding $1 billion. The firm typically invests at the pre-seed, seed, seed-plus, and Series A stages, with check sizes ranging from $1 million to $8 million, with a sweet spot around $5 million.
In addition to financial support, Sonder Capital provides hands-on guidance to its portfolio companies, leveraging the extensive experience and network of its team. The firm actively engages with founders, helping them navigate the complexities of the healthcare market. Sonder Capital's commitment to diversity is evident in its acceptance of direct pitches from underrepresented individuals, further enhancing its investment approach.
Sonder Capital's team has been involved with several notable companies that have created significant value in the healthcare sector. Key portfolio companies include:
These companies exemplify Sonder Capital's focus on transformational healthcare innovations and its ability to generate substantial returns through successful exits.
Kate Garrett - Co-Founder & Managing Partner. Garrett has extensive experience in venture capital and healthcare, currently leading the firm's second fund.
Fred Moll, M.D. - Co-Founder & Partner. Moll is a legendary medtech entrepreneur, co-founder of Intuitive Surgical, and has been involved with several successful healthcare companies.
Jay Watkins - Co-Founder & Partner. Watkins brings a wealth of experience in the medtech sector, contributing to the firm's strategic direction.
Colby Wood - Co-Founder & Partner, Capital Formation. Wood focuses on capital raising and investor relations for the firm.
Deborah Kilpatrick - Partner. Kilpatrick is a former CEO of Evidation Health and co-founder of MedtechWomen, bringing valuable insights to the team.
Dr. Todd Brinton - Venture Partner. Brinton has a strong background in medical technology and innovation.
Marisa Meehan - Director of Operations & IR. Meehan oversees operations and investor relations, ensuring smooth communication within the firm.
Ravina Harding - Executive Assistant. Harding supports the team in various administrative capacities.
To pitch Sonder Capital, founders should email their pitch deck or a one-page overview to closethegap@sondercapital.com. It is important to include a clear description of the startup's mission, the problem it solves, and the potential market impact. The firm values direct pitches from underrepresented individuals in the venture capital community. Response times may vary, but founders can expect to hear back regarding their submissions.
As of October 2023, Sonder Capital is actively raising its second fund, with Kate Garrett named as Managing Partner for Fund II. The firm continues to engage with early-stage healthcare startups, providing strategic advice and support throughout their development.
Notable exits from the firm's network include Intuitive Surgical, Shockwave Medical, and Auris Health, which collectively represent over $180 billion in value created in the healthcare sector.
What are Sonder Capital's investment criteria?
Sonder Capital focuses on early-stage startups in the medical device, diagnostic, and healthtech sectors. They seek transformational innovations that can significantly impact patient outcomes and aim for a market capitalization of over $1 billion.
How can founders pitch to Sonder Capital?
Founders can submit their pitch decks or one-page overviews via email to closethegap@sondercapital.com. The firm encourages pitches from underrepresented individuals in the venture capital community.
What makes Sonder Capital different from other venture firms?
The firm is distinguished by its deep operator pedigree in medtech, with co-founders who have led successful healthcare companies. Sonder Capital emphasizes active engagement with portfolio companies, providing strategic support throughout their lifecycle.
What is Sonder Capital's geographic focus?
Sonder Capital primarily invests in startups based in the United States, concentrating on the healthcare sector.
What is the typical check size for investments?
Sonder Capital typically invests between $1 million and $8 million, with a sweet spot around $5 million for early-stage companies.
What kind of post-investment involvement does Sonder Capital have?
The firm provides hands-on support and strategic guidance to its portfolio companies, helping them navigate the complexities of the healthcare market and achieve successful exits.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.